Paradigm Health delivers greater efficiency, faster patient recruitment, and higher-quality data through a provider and site-friendly infrastructure embedded within the industry’s largest network of community and academic research sites.
Paradigm Health delivers a unified, AI-powered research model for Phase I- IV clinical trials that optimizes protocol design, activates high-performing sites, improves enrollment performance, and automates data capture. We make clinical trials accessible to any patient, anywhere, while reducing the burden on providers.
The Paradigm Health Difference
The Paradigm Health Platform
Our AI-driven platform connects directly with providers’ systems and workflows to accelerate feasibility and patient identification, improve representative enrollment while delivering cleaner, more reliable data trial sponsors faster.
Fully Integrated Provider Network
We are the end-to-end research partner of choice for community healthcare providers and academic medical centers across the United States, Japan, and Israel. Our deep network intelligence enables us to select the best sites for any trial.
Deep Trial Expertise
Our in-house experts, including practicing oncologists, work directly with sponsors to derive rich insights and actionable recommendations from our data and clinical practice.
An End-to-End Solution
Learn More ⬇
Learn More ⬇
Design
Work with experts and real-time data to design protocols that match actual clinical practice, which is key to effective enrollment, and can seamlessly lead to site identification.
Assess
Identify and assess sites to yield the highest enrollment by using rich provider data (complete clinical/genomic longitudinal patient data from EHRs and other sources) to see where patients are being treated and operational insights (e.g., concurrent trials) to find sites that will prioritize your study.
Optimize
Identify and implement strategic adjustments to trial design, recruitment approaches, and site selection to drive better outcomes and ensure your study stays on track.
Accelerate
Increase speed and avoid costly surprises using AI-driven software to prescreen patients and navigate them to consent and enrollment with ease.
.png)
Automate
Take action and make critical decisions faster by automating all eCRFs through direct data capture, structured data extraction, and LLM-powered document processing - all with built-in source verification and AI-guided workflows that ensure full traceability and user trust.
A proven partner to execute your evidence strategy
Paradigm Health is rebuilding trial delivery for the demands of modern late phase and post approval research with advanced AI and site-based technology.
We offer full-service support for the design and execution of late-phase interventional, observational, and pragmatic trials, including protocol design, start-up, execution, and close-out.
Paradigm Health delivers fit-for-purpose evidence with greater reliability, improved efficiency, and reduced burden for sites and patients.
Paradigm Health’s Clinical Trial Network
6.5x faster enrollment
Multiple Myeloma trial: Paradigm Health's approach led to enrollment that was ~20-30% cheaper and ~6.5x faster compared to traditional approaches.
25+ sites identified
Triple-negative breast cancer trial: Paradigm Health identified 27 US community oncology sites with a high volume of racially and ethnically diverse potentially eligible patients.
>10% of total trial enrollment
Ph II ultra-rare disease basket trial: Over 10% of total trial enrollment was driven by Paradigm Health, including the first-patient-in on one of the rare, biomarker-defined trial arms.
Paradigm Health has successfully collaborated with leading industry sponsors, including Bristol-Myers Squibb (BMS), to support mission-critical research programs.
